Targeting AKT with oridonin inhibits growth of esophageal squamous cell carcinoma in vitro and patient-derived xenografts in vivo

被引：1
|
作者：
Song, Mengqiu [1 ]
Zhao, Ran [1 ]
Xie, Hua [2 ]
Chen, Hanyong [3 ]
Liu, Kangdong [4 ]
Bode, Ann M. [3 ]
Lee, Mee-Hyun [4 ]
Dong, Zigang [3 ,4 ]
机构：
[1] Zhengzhou Univ, China US Hormel Canc Inst, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou, Henan, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai, Peoples R China
[3] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA
[4] Zhengzhou Univ, China US Hormel Canc Inst, Collaborat Innovat Ctr Henan Prov Canc Chemopreve, Dept Pathophysiol,Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4299
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4299
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo
    Song, Mengqiu
    Liu, Xuejiao
    Liu, Kangdong
    Zhao, Ran
    Huang, Hai
    Shi, Yuanyuan
    Zhang, Man
    Zhou, Silei
    Xie, Hua
    Chen, Hanyong
    Li, Yin
    Zheng, Yan
    Wu, Qiong
    Liu, Fangfang
    Li, Enmin
    Bode, Ann M.
    Dong, Zigang
    Lee, Mee-Hyun
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (07) : 1540 - 1553
  • [2] Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma
    Liu, Feifei
    Zu, Xueyin
    Xie, Xiaomeng
    Zhang, Yuanyuan
    Liu, Kangdong
    Chen, Hanyong
    Wang, Ting
    Bode, Ann M.
    Dong, Zigang
    Kim, Dong Joon
    [J]. CANCER PREVENTION RESEARCH, 2019, 12 (12) : 849 - 860
  • [3] Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
    Liu, Xuejiao
    Song, Mengqiu
    Wang, Penglei
    Zhao, Ran
    Chen, Hanyong
    Zhang, Man
    Shi, Yuanyuan
    Liu, Kangdong
    Liu, Fangfang
    Yang, Ran
    Li, Enmin
    Bode, Ann M.
    Dong, Zigang
    Lee, Mee-Hyun
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) : 1007 - 1019
  • [4] Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
    Song, Mengqiu
    Qu, Yingzi
    Jia, Huajie
    Zhang, Yunqing
    Liu, Shihui
    Laster, Kyle Vaughn
    Choi, Bu Young
    Tian, Jie
    Gu, Tingxuan
    Chen, Hanyong
    Liu, Kangdong
    Lee, Mee-Hyun
    Dong, Zigang
    [J]. MOLECULAR CARCINOGENESIS, 2024, 63 (05) : 991 - 1008
  • [5] Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts
    Ma, Fayang
    Laster, Kyle
    Nie, Wenna
    Liu, Fangfang
    Kim, Dong Joon
    Lee, Mee-Hyun
    Bai, Ruihua
    Yang, Rendong
    Liu, Kangdong
    Dong, Zigang
    [J]. JOURNAL OF CANCER, 2021, 12 (13): : 3930 - 3944
  • [6] Niclosamide ethanolamine inhibits growth of patient-derived hepatocellular carcinoma xenografts
    Chen, Bin
    Wei, Wei
    Chua, Mei-Sze
    Butte, Atul
    So, Samuel K.
    [J]. HEPATOLOGY, 2015, 62 : 459A - 459A
  • [7] HDS screening with patient-derived primary cells guided individualized therapy for esophageal squamous cell carcinoma-in vivo and vitro
    He, Xing
    Yan, Hezhong
    Hu, Jie
    Duan, Xiaowei
    Zhang, Mingjin
    Li, Haiqing
    Wang, Jiaoxue
    Gao, Qian
    Yu, Senyuan
    Hou, Xilu
    Liao, Guobin
    Guo, Shicun
    Li, Jin
    Ge, Yurong
    Chen, Xiaolan
    Wang, Wenchao
    Tang, Jun
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [8] Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models
    Hou, Wenmin
    Qin, Xia
    Zhu, Xuehua
    Fei, Maogui
    Liu, Ping
    Liu, Li
    Moon, Hanlim
    Zhang, Pingkuan
    Greshock, Joel
    Bachman, Kurtis E.
    Ye, Bang-Ce
    Wang, Hui
    Zang, Crystal Ying Qin
    [J]. ONCOLOGY REPORTS, 2013, 30 (02) : 707 - 714
  • [9] Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft
    Hsu, Che-Yuan
    Yanagi, Teruki
    Maeda, Takuya
    Nishihara, Hiroshi
    Miyamoto, Kodai
    Kitamura, Shinya
    Tokuchi, Keiko
    Ujiie, Hideyuki
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft
    Che-Yuan Hsu
    Teruki Yanagi
    Takuya Maeda
    Hiroshi Nishihara
    Kodai Miyamoto
    Shinya Kitamura
    Keiko Tokuchi
    Hideyuki Ujiie
    [J]. Scientific Reports, 13
12345